blocking agent

• 遮断薬

関

antagonist、blocker

WordNet

1. a drug that neutralizes or counteracts the effects of another drug
2. a muscle that relaxes while another contracts; "when bending the elbow the triceps are the antagonist"
3. a class of drugs that inhibit (block) some biological process (同)blocking_agent
4. a football player whose responsibility is to block players attempting to stop an offensive play
5. a substance that exerts some force or effect
6. a businessman who buys or sells for another in exchange for a commission (同)factor, broker
7. any agent or representative of a federal agency or bureau (同)federal agent
8. a representative who acts on behalf of other persons or organizations
9. an active and efficient cause; capable of producing a certain effect; "their research uncovered new disease agents"
10. how long something has existed; "it was replaced because of its age"
11. a time of life (usually defined in years) at which some particular qualification or power arises; "she was now of school age"; "tall for his eld" (同)eld
12. begin to seem older; get older; "The death of his wife caused him to age fast"
13. make older; "The death of his child aged him tremendously"
14. the act of obstructing or deflecting someones movements (同)block

PrepTutorEJDIC

1. 対立する人,敵対者,競争相手(opponent)
2. 『代理人』;周旋人 / 働き(作用)を起こすもの;作用物,薬剤 / (政府機関,特にFBI,CIAなどの)部員,機関員
3. 〈U〉(一般に)『年齢』,寿命;〈C〉(個々の)『年齢』,年 / 〈U〉成年(おとなとしての資格・権利を得る年齢;通例18または21歳) / 〈U〉『老齢』;《集合的に》老人たち / 〈U〉(人生の)『一時期』;〈C〉世代(generation) / 〈U〉〈C〉《しばしばA-》(歴史上の)『時代』 / 〈C〉《話》長い間 / 年をとる,ふける;〈物が〉古くなる / 〈年〉'を'とらせる;〈物〉'を'古びさせる

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

• 1. 重症患者における神経筋遮断剤の使用 use of neuromuscular blocking medications in critically ill patients
• 2. 成人における迅速導入気管挿管のための神経筋遮断剤（NMBA） neuromuscular blocking agents nmba for rapid sequence intubation in adults
• 3. 全身麻酔の導入 induction of general anesthesia
• 4. 重症筋無力症患者に対する麻酔 anesthesia for the patient with myasthenia gravis
• 5. 成人における選択的脊椎手術のための麻酔 anesthesia for elective spine surgery in adults

English Journal

• Integrative approach in prevention and therapy of basal cellular carcinoma by association of three actives loaded into lipid nanocarriers.

• Badea G1, Lacatusu I2, Ott C1, Badea N1, Grafu I1, Meghea A1.
• Journal of photochemistry and photobiology. B, Biology.J Photochem Photobiol B.2015 Jun;147:1-8. doi: 10.1016/j.jphotobiol.2015.03.007. Epub 2015 Mar 21.
• Basal cell carcinoma (BCC) is one of the commonest malignancies occurred on sun-exposed skin, mainly by UV-B radiation, of lighter-skinned individuals. The aim of the present study was to develop advanced drug delivery formulations used in BCC therapy that overcomes chemotherapy-induced side-effects
• PMID 25828466

• Radix Dipsaci total saponins stimulate MC3T3-E1 cell differentiation via the bone morphogenetic protein-2/MAPK/Smad-dependent Runx2 pathway.

• Niu YB1, Kong XH2, Li YH3, Fan L1, Pan YL1, Li CR1, Wu XL1, Lu TL1, Mei QB1.
• Molecular medicine reports.Mol Med Rep.2015 Jun;11(6):4468-72. doi: 10.3892/mmr.2015.3249. Epub 2015 Jan 26.
• Radix Dipsaci total saponins (RTS) are primary active components of Radix Dipsaci, which is administered orally for the treatment of osteoporosis according to Chinese Medicine. RTS have also been shown to reduce the risk of bone fractures in rats. However, the detailed molecular mechanisms underlyin
• PMID 25625570

• LCZ696: The Next Step in Improving RAS Inhibition?

• Gradman AH1.
• Current hypertension reports.Curr Hypertens Rep.2015 May;17(5):548. doi: 10.1007/s11906-015-0548-y.
• LCZ696 is a single molecule which combines the angiotensin receptor blocker valsartan with the neprilysn inhibitor sacubitril (AHU377). In the recently published PARADIGM-HF trial, LCZ696 proved superior to enalapril in reducing overall mortality, heart failure hospitalizations, and other endpoints
• PMID 25833460

Japanese Journal

• Neuritogenic activity of a genipin derivative in retinal ganglion cells is mediated by retinoic acid receptor β expression through nitric oxide/S-nitrosylation signaling

• Koriyama Yoshiki,Takagi Yusuke,Chiba Kenzo,Yamazaki Matsumi,Arai Kunizo,Matsukawa Toru,Suzuki Hirokazu,Sugitani Kayo,Kagechika Hiroyuki,Kato Satoru
• Journal of Neurochemistry 119(6), 1232-1242, 2011-12
• … Neurite outgrowth with IPRG001 requires retinoic acid receptor β (RARβ) expression, which is suppressed by an RAR blocking agent and siRNA inhibition. …
• NAID 120003628232

• スガマデクスを使用後,短時間に再手術となりロクロニウム再投与を行った1症例

• 笹川 智貴,岩崎 肇,黒沢 温 [他]
• 麻酔 60(5), 621-624, 2011-05
• NAID 40018828091

Related Links

• Blocking Agent and Detergent in ELISA

Blocking Agent and Detergent in ELISA. Peter Esser, M.Sc., Senior Scientist, Thermo Fisher Scientific. If a blocking agent is used together with detergent in ELISA, one must take into account that these reagents are competitors as far ...

• BSA Blocking agent - Immunology

BSA Blocking agent - How is work? (Sep/02/2009 ). May i know who understand how BSA working as blocking agent? What is the mechanism? Why it will able to block ELISA plate? It will able to block an empty ELISA plate surface? -LOW- ...

---

★リンクテーブル★

リンク元	「blocker」
拡張検索	「beta-adrenergic blocking agent」「alpha-adrenergic blocking agent」「spermatogenesis-blocking agent」
関連記事	「agent」「age」

「blocker」

　　[★]

• n.

• 遮断薬、ブロッカー、遮断剤、阻害薬

関

antagonist、blocking agent、inhibitor

　 　

「beta-adrenergic blocking agent」

　　[★]

• βアドレナリン遮断薬

関

beta-adrenergic antagonist、beta-adrenergic blocker

「alpha-adrenergic blocking agent」

　　[★]

• αアドレナリン遮断薬

関

alpha-adrenergic antagonist

「spermatogenesis-blocking agent」

　　[★]

• 精子形成抑制薬、精子形成抑制剤

「agent」

　　[★]

• n.

• 代行者、代理人。代理業者
• 政府職員、官吏
• ある後位をする人、ある作用をするもの。動員、動力因、作用因。(文法)動作主。科学的変化を起こさせるもの、薬品、～剤。病原体

関

agonist、agonistic、attorney、delegate、drug、etiologic agent、fomes、fomites、mediator、pathogen、pathogenic、pharmaceutical preparation、vector、vehicle

　 　 　 　 　 　

「age」

　　[★]

• n.

• 年齢、歳

• v.

• 加齢する、熟成する

関

aged、ageing、aging、year old